About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Dallas | 13,723 Studies Near You

Clinical TrialsDallas

Clinical Trials in Dallas

Discover 13,723 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4081-4100 of 13,723 trials

CompletedDose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal CancerThe purpose of this study is to determine whether topical nitroglycerin in addition to 5-flourouracil and radiation therapy are effective in the treatment of operable rectal…NCT01407107·Dallas, Texas CompletedAntidepressant Treatment at an Inner City Asthma ClinicAsthma is common with an increasing prevalence and mortality especially in low-income and minority populations. The course of asthma appears to be influenced by mood and emotions.NCT01324700·Dallas, Texas CompletedHORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use DisorderThe purpose of this study is to determine whether gabapentin enacarbil is effective in the treatment of problems with alcohol.NCT02252536·Los Angeles, California and 9 others

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

Active not recruitingStudy of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsThe goal of this interventional clinical trial is to learn about TNG260, a CoREST inhibitor, in combination with pembrolizumab in patients with advanced solid tumors with a known…NCT05887492·Santa Monica, California and 12 others

UnknownStudy of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid TumorsThis is a first-in-human, phase 1, open-label, dose-escalation study of STI-6643 administered by intravenous infusion in subjects with a relapsed/refractory advanced solid tumor.NCT04900519·San Diego, California and 4 others

CompletedPhase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseThis study assesses the effects of a new formulation of bardoxolone methyl on eGFR in Patients with Chronic Kidney Disease and Type 2 Diabetes.NCT01053936·Montgomery, Alabama and 25 others

CompletedSubcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema AttacksThe primary objectives of the study are to evaluate the safety, tolerability, and efficacy of two doses of CINRYZE with recombinant human hyaluronidase (rHuPH20) administered by…NCT01756157·Birmingham, Alabama and 22 others

CompletedRexMedical- Option* Vena Cava Filter IDE StudyThis study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary…NCT00488865·Burlingame, California and 9 others

CompletedA Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 YearsThe purpose of this study is to demonstrate the efficacy of 9-valent extraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared to placebo in the prevention of the…NCT04899336·Guntersville, Alabama and 373 others

CompletedA Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerThe purpose of this study is to assess the efficacy and safety of trabectedin+DOXIL as a third-line chemotherapy regimen (treatment) in patients with platinum-sensitive…NCT01846611·Birmingham, Alabama and 137 others

CompletedNew Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsA 48-week study to investigate the safety and effectiveness of a new compact formulation of two already FDA-approved anti-HIV drugs in subjects who have already been receiving…NCT00044577·Los Angeles, California and 75 others

CompletedGenetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart FailureThis study is being done to compare the effects of bucindolol hydrochloride (bucindolol) to metoprolol succinate (Toprol-XL) on the recurrence of symptomatic atrial…NCT01970501·Anchorage, Alaska and 96 others

CompletedHome-delivered Meals for Persons With Dementia: Which Model Delays Nursing Home Placement?This project is the pilot phase of a pragmatic randomized clinical trial comparing outcomes among older adults with Alzheimer's disease and related dementias (ADRD) receiving…NCT04850781·Clearwater, Florida and 2 others

RecruitingA First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsThis is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced…NCT05458219·Austin, Texas and 38 others

RecruitingA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsThis is a first-in-human, Phase 1/2 study to evaluate LCB84, a TROP2-directed antibody-drug conjugate, alone and in combination with an anti-PD-1 Ab, in dose escalation (Phase 1)…NCT05941507·Los Angeles, California and 7 others

Approved for marketingExpanded Access Study of TAS-102 in Patients With Metastatic Colorectal CancerThe objective of the program is to provide access to TAS-102 to patients with metastatic colorectal cancer who are refractory to or failing standard chemotherapy, are new to…NCT02286492·Birmingham, Alabama and 32 others

CompletedA Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin LymphomaThis study is a Phase 1/2 open-label three part study in patients with relapsed indolent Non-Hodgkin's lymohoma (NHL) (Parts A and C) or relapsed/refractory follicular lymphoma…NCT01796171·Little Rock, Arkansas and 95 others

CompletedA Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 DiabetesThe purpose of this study is determine whether the combination of naltrexone SR and bupropion SR is safe and effective in treating obesity in subjects with type 2 diabetes.NCT00474630·Fairhope, Alabama and 52 others

WithdrawnAlternative Treatment Paradigm for Natalizumab TrialThis study is being done to determine the difference between natalizumab therapy followed by two different withdrawal strategies using Glatiramer Acetate (GA) treatment paradigms…NCT01710228·Dallas, Texas

CompletedA Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1The primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 8700 for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS).NCT02634307·Cullman, Alabama and 114 others

PreviousPage 205 of 687Next

Heart Diseasein Dallas